Edition:
United States

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.73USD
18 Aug 2017
Change (% chg)

$-0.01 (-0.57%)
Prev Close
$1.74
Open
$1.69
Day's High
$1.75
Day's Low
$1.68
Volume
181,514
Avg. Vol
123,394
52-wk High
$3.71
52-wk Low
$1.47

CRIS.OQ

Chart for CRIS.OQ

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.96
Market Cap(Mil.): $248.91
Shares Outstanding(Mil.): 143.88
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -0.50 -- --
ROI: -124.16 2.83 14.89
ROE: -250.87 5.09 16.13

BRIEF-Curis reports Q2 loss per share $0.10

* Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Aug 03 2017

BRIEF-Curis Q1 loss per share $0.11

* Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S

May 04 2017

BRIEF-Curis Q4 loss per share $0.08

* Curis reports fourth quarter and year-end 2016 financial results

Mar 09 2017

Earnings vs. Estimates